Diabetes surge hits every nation

One in ten of the world's population will have diabetes by 2035 according to the International Diabetes Federation (IDF). The latest edition IDF Diabetes Atlas, published today on World Diabetes Day, estimates that people living with diabetes will surge from 382 million to 59 2 million people by 2035, many in low and middle income countries and the majority under 60. This surge will form the backdrop of the World Diabetes Congress (#WDC2013) in Melbourne, Australia this December.

In some Pacific Island nations there has been an alarming surge in diabetes prevalence. One adult in three has the disease on the Pacific Island of Tokelau, providing a microcosm of how diabetes could play out in more populous nations within the coming decades.Sub-Saharan Africa will see a doubling in the number of people with diabetes by 2035, the largest surge of any region in the world.

Previous estimates from the IDF Diabetes Atlas in 2012 put the number of people with diabetes at 371 million and number of deaths for 2012 at 4.8 million. The new figures show that the upward trend will continue. By the end of 2013, 5.1 million people will have died from diabetes related complications. With 175 million undiagnosed cases many people are progressing towards complications unawares.

Chinawith 98 million, India with 65 million and the USA with 24 million have the highest numbers of people with diabetes. Regionally the Western Pacific, which includes countries such as Australia, China and Japan, has 138 million people with diabetes, the highest number of people with the disease in the world.

"Diabetes is a disease of development. The misconception that diabetes is 'a disease of the wealthy' is still held, to the detriment of desperately needed funding to combat the pandemic" said Sir Michael Hirst, President of IDF speaking at the International Diabetes Leadership Forum in Istanbul, Turkey. "On World Diabetes Day, we must continue to increase awareness of the importance of a healthy diet and physical activity. Crucially, environments must be created that lay the foundations for healthy living."

Other findings from the 6th edition Diabetes Atlas include:

  • 548 billion USD were spent on diabetes in 2013
  • North America spends the most healthcare dollars on diabetes
  • In South East Asia almost half of all people with diabetes are undiagnosed
  • The Western Pacific has the largest number of people with diabetes in the world
  • In Africa, three quarters of diabetes deaths are in people under 60 years old
  • In the Middle East and North Africa, one in ten people have diabetes
  • In South and Central America, there will be a 60% increase in the number of people with diabetes within a generation

The release of these figures underlines the urgency around IDF's commitment to see diabetes and other Non-communicable Diseases (NCDs) included in an overarching health target in the post-2015 development framework. This will ensure a whole-of-society approach to prevention, treatment, care and support for diabetes and NCDs.

It is hoped that campaigns such as today's World Diabetes Day will continue to raise the voice of people with diabetes and to encourage all stakeholders to move from advocacy to action on a global scale.

About World Diabetes Day
World Diabetes Day (WDD) is celebrated every year on November 14. The World Diabetes Day campaign is led by the International Diabetes Federation (IDF) and its member associations. It engages millions of people worldwide in diabetes advocacy and awareness. World Diabetes Day was created in 1991 by the International Diabetes Federation and the World Health Organizati on in response to growing concerns about the escalating health threat that diabetes now poses. World Diabetes Day became an official United Nations Day in 2007 with the passage of United Nation Resolution 61/225. The campaign draws attention to issues of paramount importance to the diabetes world and keeps diabetes firmly in the public spotlight. This year sees the fourth of a five-year campaign that will address the growing need for diabetes education and prevention programmes.

About the International Diabetes Federation (IDF)
The International Diabetes Federation (IDF) is an umbrella organisation of over 200 national diabetes associations in over 160 countries. It represents the interests of the growing number of people with diabetes and those at risk. The Federation has been leading the global diabetes community since 1950. IDF's mission is to promote diabetes care, prevention and a cure worldwide.

Most Popular Now

Xenpozyme™ (olipudase alfa-rpcp) approved by FDA a…

The U.S. Food and Drug Administration (FDA) has approved Xenpozyme™ (olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid...

FDA grants Breakthrough Therapy Designation to Pfi…

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designat...

Malaria booster vaccine shows durable high efficac…

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of ...

Research reveals widespread use of ineffective COV…

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use...

Strict COVID lockdowns in France improved cardiova…

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measura...

Efficacy, cash and more will increase booster shot…

The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster shot with...

U.S. clinical trial evaluating antiviral for monke…

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. St...

Novartis invests in early technical development ca…

Novartis today announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will b...

Stem cell-gene therapy shows promise in ALS safety…

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This...

Drug turns cancer gene into "eat me" fla…

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now...

Mucosal antibodies in the airways protect against …

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three ...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a 30-µg booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 vaccine (COMIRNATY® Original/Om...